Consultation outcome

Consultation on provisional decisions on reviews of three merger undertakings and one market investigation Order

This consultation has concluded

Detail of outcome

The CMA has published its final decisions that the remedies under review should be released (in the case of the undertakings) and revoked (in the case of the order). The CMA’s final decisions with reasoning and Notice of Release/Revocation can be found on the CMA’s remedy review case page.


Original consultation

Summary

The CMA is seeking views from interested stakeholders for its reviews of three merger remedies and one market investigation Order.

This consultation ran from
to

Consultation description

The CMA has made provisional decisions that, due to relevant changes in circumstances, the following CMA remedies are no longer appropriate and should be released/revoked:

The CMA consulted on changes in circumstance and consequent potential outcomes in its launch decision consultation, which ran from 21 November 2023 to 12 December 2023.

We are keen to receive relevant evidence from interested parties to help us reach final decisions on these reviews.

Respondents should provide their views supported with relevant evidence where possible, in writing to the CMA at the address below by 5pm on Monday 12 December 2023. We will then consider the views and evidence received before reaching final decisions.

Further information on this review can be found on our case page.

The CMA requests that all submissions be accompanied by a non-confidential version which the respondent would be willing to have published on the CMA website when we publish our provisional decision.

Documents

Updates to this page

Published 19 March 2024
Last updated 10 July 2024 + show all updates
  1. Detail of outcome published.

  2. First published.

Sign up for emails or print this page